Stay updated on Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe page revision was updated to v3.6.4, indicating a backend update to the ClinicalTrials.gov page. This update appears to be a software version change rather than a modification to study details.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision tag v3.6.3 was added and the previous v3.6.2 tag was removed from the page, updating the revision history.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page's revision label updated from v3.6.0 to v3.6.2, indicating a minor behind-the-scenes update to the page version.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page adds a line indicating recruitment is closed ('No longer looking for participants') and introduces new or reorganized sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', plus a Revision: v3.6.0 notice.SummaryDifference0.3%

- Check56 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a newer version of the page.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a minor version update rather than a substantive change to the study details.SummaryDifference0.0%

Stay in the know with updates to Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.